Prothena Corp (PRTA, Financial) continues to hold a "Neutral" rating as confirmed by analyst Eric Schmidt from Cantor Fitzgerald. The rating was reiterated on June 20, 2025, indicating that there has been no change in the company's projected performance outlook according to this analyst.
While no specific price target has been set or adjusted in this update, the reaffirmation of the "Neutral" rating for PRTA reflects a steady perspective by Cantor Fitzgerald regarding the stock's current standing and future prospects.
Investors tracking Prothena Corp (PRTA, Financial) will be keen to observe any future updates from analysts that could provide further insights into the company's trajectory and market performance.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 8 analysts, the average target price for Prothena Corp PLC (PRTA, Financial) is $29.00 with a high estimate of $81.00 and a low estimate of $4.00. The average target implies an upside of 404.35% from the current price of $5.75. More detailed estimate data can be found on the Prothena Corp PLC (PRTA) Forecast page.
Based on the consensus recommendation from 9 brokerage firms, Prothena Corp PLC's (PRTA, Financial) average brokerage recommendation is currently 2.7, indicating "Hold" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Prothena Corp PLC (PRTA, Financial) in one year is $28.40, suggesting a upside of 393.91% from the current price of $5.75. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Prothena Corp PLC (PRTA) Summary page.
